Trent Munro

Professor Trent Munro is a Biotechnology and Biopharmaceutical professional with extensive experience in the CMC development of a wide array of biological and synthetic therapeutic modalities.

He is currently a Senior Group Leader at the Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland where he is Director of the NCRIS Funded National Biologics Facility and Program Director for the CEPI funded Vaccine Rapid Response pipeline. In this role has been part of the UQ team developing a clinical stage vaccine candidate for COVID-19.

Professor Munro’s research is focussed on the development, engineering and production of complex therapeutics using biological system. This includes engineering mammalian cells in order to improve their efficiency and utility in the production of complex proteins, with a focus on biopharmaceuticals.